Search

Displaying results 7481 - 7490 of 9667 in total
  1. Drug

    CP-724714

    go.drugbank.com/drugs/DB12302
    Investigational

    CP-724,714 has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasm Metastasis.

  2. Drug

    Nepadutant

    go.drugbank.com/drugs/DB12538
    Investigational

    Nepadutant has been used in trials studying the treatment of Colic, Infantile Colic, and Infantile Functional Gastrointestinal Disorders.

  3. Drug

    Setipiprant

    go.drugbank.com/drugs/DB12562
    Investigational

    Setipiprant has been investigated for the treatment of Seasonal Allergic Rhinitis, asthma and scalp hair loss (Androgenetic Alopecia).

  4. Drug

    QAV-680

    go.drugbank.com/drugs/DB11658
    Investigational

    QAV680 has been used in trials studying the treatment of Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis.

  5. Drug

    Landogrozumab

    go.drugbank.com/drugs/DB11862
    Investigational

    Landogrozumab has been used in trials studying the treatment of Advanced Cancer, Muscular Atrophy, and Pancreatic Cancer.

  6. Drug

    Bindarit

    go.drugbank.com/drugs/DB12739
    Investigational

    Bindarit has been used in trials studying the prevention and treatment of Coronary Restenosis and Diabetic Nephropathy.

  7. Drug

    DTP-348

    go.drugbank.com/drugs/DB12741
    Investigational

    Dtp348 has been used in trials studying the treatment of Solid Tumors and Head and Neck Neoplasms.

  8. Drug

    Albusomatropin

    go.drugbank.com/drugs/DB12950
    Investigational

    Albusomatropin has been used in trials studying the treatment of Growth Hormone-Deficiency and Growth Hormone Deficiency.

  9. Drug

    Mitoguazone

    go.drugbank.com/drugs/DB12967
    Investigational

    Mitoguazone has been used in trials studying the treatment of Lymphoma, HIV Infections, and Lymphoma, Non-Hodgkin.

  10. Drug

    CHS-828

    go.drugbank.com/drugs/DB12980
    Investigational

    CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.